QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online 11 April 2007
doi: 10.1242/dev.002402

This Article Figures Only Full Text Full Text (PDF) Supplementary Material All Versions of this Article: dev.002402v1 134/10/1833    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vieira, J. M. Articles by Ruhrberg, C. Search for Related Content PubMed PubMed Citation Articles by Vieira, J. M. Articles by Ruhrberg, C. Social Bookmarking                         What's this?

Selective requirements for NRP1 ligands during neurovascular patterning

Institute of Ophthalmology, University College London, 11-43 Bath Street, London EC1V 9EL, UK.

^* Author for correspondence (e-mail: c.ruhrberg{at}ucl.ac.uk)

Accepted 27 February 2007

Blood vessels and neurons share several types of guidance cues and cell surface receptors to control their behaviour during embryogenesis. The transmembrane protein NRP1 is present on blood vessels and nerves. NRP1 binds two structurally diverse ligands, the semaphorin SEMA3A and the VEGF164 isoform of vascular endothelial growth factor. SEMA3A was originally identified as a repulsive cue for developing axons that acts by signalling through receptor complexes containing NRP1 and plexins. In vitro, SEMA3A also inhibits integrin function and competes with VEGF164 for binding to NRP1 to modulate the migration of endothelial cells. These observations resulted in a widely accepted model of vascular patterning in which the balance of VEGF164 and SEMA3A determines endothelial cell behaviour. However, we now demonstrate that SEMA3A is not required for angiogenesis in the mouse, which instead is controlled by VEGF164. We find that SEMA3A, but not VEGF164, is required for axon patterning of limb nerves, even though the competition between VEGF164 and SEMA3A for NRP1 affects the migration of neuronal progenitor cells in vitro and has been hypothesised to control axon guidance. Moreover, we show that there is no genetic interaction between SEMA3A and VEGF164 during vasculogenesis, angiogenesis or limb axon patterning, suggesting that ligand competition for NRP1 binding cannot explain neurovascular congruence, as previously suggested. We conclude that NRP1 contributes to both neuronal and vascular patterning by preferentially relaying SEMA3A signals in peripheral axons and VEGF164 signals in blood vessels.

Key words: VEGF, Neuropilin, Semaphorin, Mouse

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				Q. Schwarz, C. H. Maden, K. Davidson, and C. Ruhrberg Neuropilin-mediated neural crest cell guidance is essential to organise sensory neurons into segmented dorsal root ganglia Development, June 1, 2009; 136(11): 1785 - 1789. [Abstract] [Full Text] [PDF]

				I. Eshkar-Oren, S. V. Viukov, S. Salameh, S. Krief, C.-d. Oh, H. Akiyama, H.-P. Gerber, N. Ferrara, and E. Zelzer The forming limb skeleton serves as a signaling center for limb vasculature patterning via regulation of Vegf Development, April 15, 2009; 136(8): 1263 - 1272. [Abstract] [Full Text] [PDF]

				Q. Schwarz, C. H. Maden, J. M. Vieira, and C. Ruhrberg Neuropilin 1 signaling guides neural crest cells to coordinate pathway choice with cell specification PNAS, April 14, 2009; 106(15): 6164 - 6169. [Abstract] [Full Text] [PDF]

				C. Ruiz de Almodovar, D. Lambrechts, M. Mazzone, and P. Carmeliet Role and Therapeutic Potential of VEGF in the Nervous System Physiol Rev, April 1, 2009; 89(2): 607 - 648. [Abstract] [Full Text] [PDF]

				B. Larrivee, C. Freitas, S. Suchting, I. Brunet, and A. Eichmann Guidance of Vascular Development: Lessons From the Nervous System Circ. Res., February 27, 2009; 104(4): 428 - 441. [Abstract] [Full Text] [PDF]

				H. Kawamura, X. Li, K. Goishi, L. A. van Meeteren, L. Jakobsson, S. Cebe-Suarez, A. Shimizu, D. Edholm, K. Ballmer-Hofer, L. Kjellen, et al. Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization Blood, November 1, 2008; 112(9): 3638 - 3649. [Abstract] [Full Text] [PDF]

				A. Varshavsky, O. Kessler, S. Abramovitch, B. Kigel, S. Zaffryar, G. Akiri, and G. Neufeld Semaphorin-3B Is an Angiogenesis Inhibitor That Is Inactivated by Furin-Like Pro-Protein Convertases Cancer Res., September 1, 2008; 68(17): 6922 - 6931. [Abstract] [Full Text] [PDF]

				E. A. V. Jones, L. Yuan, C. Breant, R. J. Watts, and A. Eichmann Separating genetic and hemodynamic defects in neuropilin 1 knockout embryos Development, July 15, 2008; 135(14): 2479 - 2488. [Abstract] [Full Text] [PDF]

				G. Serini, L. Napione, M. Arese, and F. Bussolino Besides adhesion: new perspectives of integrin functions in angiogenesis Cardiovasc Res, May 1, 2008; 78(2): 213 - 222. [Abstract] [Full Text] [PDF]

				G. M. Tozer, S. Akerman, N. A. Cross, P. R. Barber, M. A. Bjorndahl, O. Greco, S. Harris, S. A. Hill, D. J. Honess, C. R. Ireson, et al. Blood Vessel Maturation and Response to Vascular-Disrupting Therapy in Single Vascular Endothelial Growth Factor-A Isoform-Producing Tumors Cancer Res., April 1, 2008; 68(7): 2301 - 2311. [Abstract] [Full Text] [PDF]